121 related articles for article (PubMed ID: 29211179)
1. Survival analysis of women with breast cancer: competing risk models.
Ferraz RO; Moreira-Filho DC
Cien Saude Colet; 2017 Nov; 22(11):3743-3754. PubMed ID: 29211179
[TBL] [Abstract][Full Text] [Related]
2. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
[TBL] [Abstract][Full Text] [Related]
3. Different survival analysis methods for measuring long-term outcomes of Indigenous and non-Indigenous Australian cancer patients in the presence and absence of competing risks.
He VY; Condon JR; Baade PD; Zhang X; Zhao Y
Popul Health Metr; 2017 Jan; 15(1):1. PubMed ID: 28095862
[TBL] [Abstract][Full Text] [Related]
4. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death.
Nagar H; Yan W; Christos P; Chao KSC; Nori D; Ravi A
Am J Clin Oncol; 2017 Jun; 40(3):300-305. PubMed ID: 25333731
[TBL] [Abstract][Full Text] [Related]
5. [Five-year survival and prognostic factors in women with breast cancer in Santa Catarina State, Brazil].
Schneider IJ; d'Orsi E
Cad Saude Publica; 2009 Jun; 25(6):1285-96. PubMed ID: 19503959
[TBL] [Abstract][Full Text] [Related]
6. Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
Chen HL; Zhou MQ; Tian W; Meng KX; He HF
PLoS One; 2016; 11(10):e0165409. PubMed ID: 27798652
[TBL] [Abstract][Full Text] [Related]
7. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
8. [Survival of women with breast cancer, of a city in the south of Brazil].
Ayala AL
Rev Bras Enferm; 2012; 65(4):566-70. PubMed ID: 23258674
[TBL] [Abstract][Full Text] [Related]
9. Ascertaining prognosis for breast cancer in node-negative patients with innovative survival analysis.
Chapman JA; Lickley HL; Trudeau ME; Hanna WM; Kahn HJ; Murray D; Sawka CA; Mobbs BG; McCready DR; Pritchard KI
Breast J; 2006; 12(1):37-47. PubMed ID: 16409585
[TBL] [Abstract][Full Text] [Related]
10. [Five-year survival and prognostic factors in a cohort of breast cancer patients treated in Juiz de Fora, Minas Gerais State, Brazil].
Guerra MR; Mendonça GA; Bustamante-Teixeira MT; Cintra JR; Carvalho LM; Magalhães LM
Cad Saude Publica; 2009 Nov; 25(11):2455-66. PubMed ID: 19936483
[TBL] [Abstract][Full Text] [Related]
11. [Survival rate of 10 years among women with breast cancer: a historic cohort from 2000-2014].
Ayala ALM; Anjos JCD; Cassol GA; Höfelmann DA
Cien Saude Colet; 2019 Apr; 24(4):1537-1550. PubMed ID: 31066855
[TBL] [Abstract][Full Text] [Related]
12. Survival rates of breast cancer and predictive factors: a hospital-based study from western Amazon area in Brazil.
Fujimoto RHP; Koifman RJ; Silva IFD
Cien Saude Colet; 2019 Jan; 24(1):261-273. PubMed ID: 30698259
[TBL] [Abstract][Full Text] [Related]
13. Application of accelerated failure time models for breast cancer patients' survival in Kurdistan Province of Iran.
Karimi A; Delpisheh A; Sayehmiri K
J Cancer Res Ther; 2016; 12(3):1184-1188. PubMed ID: 28054533
[TBL] [Abstract][Full Text] [Related]
14. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma.
Hanrahan EO; Gonzalez-Angulo AM; Giordano SH; Rouzier R; Broglio KR; Hortobagyi GN; Valero V
J Clin Oncol; 2007 Nov; 25(31):4952-60. PubMed ID: 17971593
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the Cox model to the Fine-Gray model for survival analyses of re-fracture rates.
Nolan EK; Chen HY
Arch Osteoporos; 2020 Jun; 15(1):86. PubMed ID: 32519193
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Weibull and Lognormal Cure Models with Cox in the Survival Analysis Of Breast Cancer Patients in Rafsanjan.
Hoseini M; Bahrampour A; Mirzaee M
J Res Health Sci; 2017 Feb; 17(1):e00369. PubMed ID: 28413171
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer survival and health iniquities.
Guerra MR; Silva GA; Nogueira MC; Leite IC; Oliveira Rde V; Cintra JR; Bustamante-Teixeira MT
Cad Saude Publica; 2015 Aug; 31(8):1673-84. PubMed ID: 26375646
[TBL] [Abstract][Full Text] [Related]
18. The tumor-to-breast volume ratio (TBR) predicts cancer-specific survival in breast cancer patients who underwent modified radical mastectomy.
Wen J; Ye F; Huang X; Li S; Yang L; Xiao X; Xie X
Tumour Biol; 2016 Jun; 37(6):7493-500. PubMed ID: 26678892
[TBL] [Abstract][Full Text] [Related]
19. The influence of cosmetic breast augmentation on the stage distribution and prognosis of women subsequently diagnosed with breast cancer.
Xie L; Brisson J; Holowaty EJ; Villeneuve PJ; Mao Y
Int J Cancer; 2010 May; 126(9):2182-90. PubMed ID: 19569048
[TBL] [Abstract][Full Text] [Related]
20. Serum enterolactone levels and mortality outcome in women with early breast cancer: a retrospective cohort study.
Guglielmini P; Rubagotti A; Boccardo F
Breast Cancer Res Treat; 2012 Apr; 132(2):661-8. PubMed ID: 22094938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]